Ligase I, DNA, ATP-Dependent (LIG1) (Middle Region) Peptide
Quick Overview for Ligase I, DNA, ATP-Dependent (LIG1) (Middle Region) Peptide (ABIN979314)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Sequence
- PSVTSFILDT EAVAWDREKK QIQPFQVLTT RKRKEVDASE IQVQVCLYAF
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-LIG1 Antibody(ARP54308_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- LIG1 (Ligase I, DNA, ATP-Dependent (LIG1))
-
Background
-
LIG1is DNA ligase I, with functions in DNA replication and the base excision repair process. Mutations in LIG1 that lead to DNA ligase I deficiency result in immunodeficiency and increased sensitivity to DNA-damaging agents.
Alias Symbols: MGC117397, MGC130025
Protein Interaction Partner: PCNA,CSNK2A1,INPP1,MRE11A,PCNA,TUBB3,MRE11A,PCNA,UBC
Protein Size: 919 -
Molecular Weight
- 102 kDa
-
Gene ID
- 3978
-
NCBI Accession
- NM_000234, NP_000225
-
UniProt
- P18858
Target
-